US Patent 9155723 Anti-CXCR4 as a sensitizer to cancer therapeutics
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+313 characters)
Article
Patent abstract
Inhibition of CXCR4 can inhibit tumor growth and metastasis during certain therapeutic windows. Disclosed are novel methods for treating and preventing cancer in a subject related to administration of CXCR4 inhibitors during a therapeutic window following treatment with another anti-tumor therapy.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09155723 Anti-CXCR4 as a sensitizer to cancer therapeutics US Patent 9155723 Anti-CXCR4 as a sensitizer to cancer therapeutics
Infobox
Patent Number
091557230
Patent Number
91557230
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
091557230
Date of Patent
October 13, 2015
0Patent Application Number
138069290
Date Filed
June 28, 2011
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09155723 Anti-CXCR4 as a sensitizer to cancer therapeutics
Infobox
Is a
Patent jurisdiction
Patent number
09155723
Date of patent
October 13, 2015
Patent application number
13806929
Date Filed
June 28, 2011
Patent primary examiner
Find more entities like US Patent 9155723 Anti-CXCR4 as a sensitizer to cancer therapeutics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.